<?xml version="1.0" encoding="UTF-8"?>
<p>In alloxan-induced diabetic Wistar rats, both aqueous and ethanolic leaf extracts of 
 <italic>E. psoraleoides</italic> (at 200 and 400 mg/kg) significantly decreased fasting blood glucose levels from day 6 of a 7-days treatment (
 <xref rid="B126" ref-type="bibr">Nduka et al., 2018</xref>; 
 <xref rid="B127" ref-type="bibr">Nduka et al., 2019</xref>). Using the same model, 
 <xref rid="B54" ref-type="bibr">Elechi et al. (2019)</xref> investigated the effects of 
 <italic>n</italic>-hexane, 
 <italic>n</italic>-hexane/dichloromethane (1:1 v/v), dichloromethane, and dichloromethane/methanol (19:1 v/v) fractions of the 
 <italic>n</italic>-hexane leaf extract of 
 <italic>E. psoraleoides</italic> on the fasting blood glucose levels. The 
 <italic>n</italic>-hexane/dichloromethane and the dichloromethane fractions at the dose of 200 mg/kg produced a significant decrease in fasting blood glucose levels from day 2–7, the effects of the dichloromethane fraction being higher or very close to that of 4 mg/kg glibenclamide (
 <xref rid="B54" ref-type="bibr">Elechi et al., 2019</xref>).
</p>
